Cuttica, Alessandra <br/><br/>
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.  [electronic resource] 

 -  Cancer  Sep 2003 
 - 983-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.11610  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Peripheral Blood Stem Cell Transplantation<br/>Prognosis<br/>Treatment Outcome